European Union lawmakers are being urged to avoid too much risk aversion from holding back the potential of the homegrown biotech sector. Beyond huge promise in healthcare, innovative, low carbon applications in areas like agriculture and food systems and energy production could help address pressing environmental and sustainability challenges.